Cortex Reacquires all AMPAKINE® Compounds, Related Patents and Exclusive Global Rights for Respiratory Depression from …
Cortex Reacquires all AMPAKINE® Compounds, Related Patents and Exclusive Global Rights for Respiratory Depression from …
IRVINE, Calif.–(BUSINESS WIRE)–CORTEX REACQUIRES ALL AMPAKINE® COMPOUNDS, RELATED PATENTS AND EXCLUSIVE GLOBAL RIGHTS FOR RESPIRATORY DEPRESSION FROM BIOVAIL.
Read more on Business Wire
Press Release
Cortex Pharmaceuticals Inc. Posted on:16 Mar 11 Cortex Pharmaceuticals, Inc. (OTCBB: CORX) announced that it has entered into an agreement with Biovail Laboratories International SRL (“Biovail”), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. (“Valeant”), to regain the AMPAKINE® assets and rights related to respiratory depression.
Read more on PharmiWeb
Categories: News Tags: AMPAKINE®, Compounds, Cortex, Depression, Exclusive, From, Global, Patents, Reacquires, Related, Respiratory, Rights
Glidewell Dental Lab Becomes Exclusive U.S. Distributor of aveoTSD® Anti-Snoring Device
Glidewell Dental Lab Becomes Exclusive U.S. Distributor of aveoTSD® Anti-Snoring Device
Glidewell Dental Lab announces its newest offering, the aveoTSD. A simple, clinically proven treatment for Sleep Disordered Breathing, this life-altering anti-snoring device is available through dentist or physician prescription.
Read more on PRWeb via Yahoo! News
A funny thing happened on the way to the mosque
An increasing number of Britons are converting to Islam. Mosques are open to the public, so it is possible simply to wander in and try the religion for size?
Read more on Times Online
Categories: News Tags: AntiSnoring, aveoTSD®, Becomes, Dental, Device, Distributor, Exclusive, Glidewell, U.S.